Awesome post. This reminds me of an article from 2007 I read on the weekend. It's 50 odd pages but well worth the read if you have the time. Very helpful if anyone wants more information on:
- method of action and the science behind why pentosan can do what it does
- the potential pipeline of indications, in case you were worried the company is a one trick pony - ie. OA or bust
- context behind why PPS has yet to be commercialised beyond elmiron and animal use
- PAR's links to Biopharm/Arthropharm (the maker of Cartrophen Vet) through Prof Peter Ghosh
http://www.naturalmedicine.net.nz/wp-content/uploads/2013/10/1-Polisulfate-to-PDF1.pdf
PAR - Forget me not!, page-9
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 181098 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 118621 | 5 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |